KDM5B and neoplasm: KDM5B contributes to hepatocellular carcinoma progression through the miR-448/YTHDF3/ITGA6 axis, and KDM5B inactivates PTEN, while silencing KDM5B reduces tumor cell proliferation and induces cell cycle arrest.